Measuring and Promoting SARS-CoV-2 Vaccine Equity: Development of a COVID-19 Vaccine Equity Index
Purpose: The coronavirus pandemic has created the greatest public health crisis in a century, causing >500,000 deaths in the United States alone. Minoritized and socioeconomically disadvantaged groups have borne a disproportionate burden of severe illness, hospitalization, and death from COVID-19...
Saved in:
Format: | Book |
---|---|
Published: |
Mary Ann Liebert,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VITT with inactivated SARS-CoV-2 vaccine - index case
by: Kanta Devi, et al.
Published: (2022) -
SARS-CoV-2 reinfection and implications for vaccine development
by: Firzan Nainu, et al.
Published: (2020) -
SARS-CoV-2 vaccine candidates in rapid development
by: Lifeng Li, et al.
Published: (2021) -
Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'
by: Kuldeep Dhama, et al.
Published: (2020) -
COVID-19 vaccine equity in the Americas
by: The Lancet Regional Health- Americas
Published: (2022)